)
ProMIS Neurosciences (PMN) investor relations material
ProMIS Neurosciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 20, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 19, 2026.
Voting matters and shareholder proposals
Election of seven directors to serve until the next annual meeting or until successors are elected.
Ratification of Baker Tilly US, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval of an amendment to the 2025 Stock Option and Incentive Plan.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Seven nominees listed for director positions, including Eugene Williams, Neil Cashman, Joshua Mandel-Brehm, Maggie Shafmaster, Neil K. Warma, William Wyman, and Slanix Alex.
- Phase 1b Alzheimer's trial fully enrolled; key data and platform validation expected this year.PMN
Guggenheim Securities Emerging Outlook: Biotech Summit 202613 Apr 2026 - Shareholders will vote on board elections, auditor ratification, and expanding the stock option plan.PMN
Proxy filing9 Apr 2026 - Up to $200M in securities, including $50M ATM, to fund neurodegenerative drug development.PMN
Registration filing25 Mar 2026 - PRECISE-AD trial fully enrolled; strong safety, major financing, and top-line data expected 2027.PMN
Q4 202525 Mar 2026 - Biotech registers 13.8M shares for resale after $75.5M private placement to fund clinical trials.PMN
Registration Filing18 Mar 2026 - Phase Ib Alzheimer's trial shows no ARIA cases, with interim results due Q2 next year.PMN
H.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025 - Phase 1b Alzheimer’s trial of PMN 310 advances, aiming for safer, more effective outcomes.PMN
Guggenheim SMID Cap Biotech Conference24 Dec 2025 - Up to $50M in securities offered, with $17.99M ATM for clinical and corporate use; high dilution risk.PMN
Registration Filing16 Dec 2025 - 56.5M shares registered for resale after $30.3M private placement to fund neurodegenerative drug trials.PMN
Registration Filing16 Dec 2025
Next ProMIS Neurosciences earnings date
Next ProMIS Neurosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage